No credit card. No commitment.
5000+ G2 reviews
TG Therapeutics, Inc.
Research
Public company
Founded in 2011
New York, New YorkTG Therapeutics, Inc.
ResearchPublic companyFounded in 2011New York, New York
EmployeesTG Therapeutics, Inc.'s financial review
TG Therapeutics, Inc.'s Revenue (Yearly)
180M
Employees
360
Total Funding
314.8M
Last Funding Round
200M
nasdaq
TGTX
Market cap
2.6B
TG Therapeutics, Inc. information
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to tr...
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
TG Therapeutics, Inc. industries
Biotechnology
Hematological malignancies
Nonhodgkins lymphoma
Multiple sclerosis
TG Therapeutics, Inc.'s financial review
TG Therapeutics, Inc.'s Revenue (Yearly)
180M
Employees
360
Total Funding
314.8M
Last Funding Round
200M
nasdaq
TGTX
Market cap
2.6B
Employee Metrics
Technologies
Domain Name Services
Hosting
Customer Relationship Management
Email Providers
Other
Notable Alumni
Job Postings
United States
United States
Employees
Accounts Payable Manager
Real Estate Agent
Chief Technology Officer
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
